Dr Corey Goodman

President, Biotherapeutics and Bioinnovation Center, Pfizer Inc.

Dr Corey Goodman has been Member of the Supervisory Board of Evotec since August 2008 and is a Member of the Evotec Scientific Advisory Board. He was appointed President of Pfizer's Biotherapeutics and Bioinnovation Center in October 2007, is an Executive Officer of Pfizer and serves as a Member of the Pfizer Executive Leadership Team.

Prior to joining Pfizer, Dr Goodman was a Professor at Stanford University and the University of California (U.C.) Berkeley. While on the faculty at U.C. Berkeley, he served as the Evan Rauch Professor of Neuroscience, the Director of the Wills Neuroscience Institute, and an Investigator with the Howard Hughes Medical Institute. He currently serves as Adjunct Professor at the U.C. San Francisco. Dr Goodman is an elected Member of the U.S. National Academy of Sciences.

During his career, Dr Goodman has advised numerous biotechnology companies, and co-founded two: Exelixis and Renovis. He served as President and Chief Executive Officer of Renovis from 2001 until 2007 when the company's merger with Evotec was announced.

Dr Goodman attended Stanford University as a Searle Scholar and earned his B.S. in Biology with distinction and honors. He was an NSF Fellow at the U.C. Berkeley and earned his PhD in Neurobiology, and was then a Helen Hay Whitney Postdoctoral Fellow at U.C. San Diego.

Among his many public service roles, Dr Goodman is Vice President of the McKnight Endowment Fund for Neuroscience and a Board Member of the Biotechnology Industry Organization (BIO) and California Council on Science and Technology.